{"nct_id":"NCT05827614","title":"Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-03-24","start_date_type":"ACTUAL","primary_completion_date":"2026-09-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03-31","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["BOLD"]}